Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-21-001229
Filing Date
2021-03-30
Accepted
2021-03-30 13:26:57
Documents
45
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K zk2125811.htm 10-K 593684
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 8397
3 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 3903
10 image2.jpg GRAPHIC 33539
  Complete submission text file 0001178913-21-001229.txt   2326027

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT atms-20201231.xml EX-101.INS 360503
5 XBRL TAXONOMY EXTENSION SCHEMA atms-20201231.xsd EX-101.SCH 26344
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20201231_cal.xml EX-101.CAL 25431
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20201231_def.xml EX-101.DEF 84860
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20201231_lab.xml EX-101.LAB 176285
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20201231_pre.xml EX-101.PRE 137206
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24431 | Film No.: 21785360
SIC: 2890 Miscellaneous Chemical Products